Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to the newest version of your browser.

Your browser appears to have cookies disabled. For the best experience of Construction News, please enable cookies in your browser.

Welcome to the Construction News site. As we have relaunched, you will have to sign in once now and agree for us to use cookies, so you won't need to log in each time you visit our site.
Learn more

Hampstead's Royal Free enters phase 2 of global centre to tackle cancer and HIV

The Royal Free London NHS Foundation Trust is offering up to £50m of work as it develops “one of the five leading global research centres for immunity” targeting cancer and HIV.

The Royal Free charity is seeking expressions of interest on a 36-month framework, worth between £25m and £50m, for its Medical Research and Clinical Trials New Build Phase 2, a new academic building on the trust’s campus in Pond Street, Hampstead.

Phase one is already under way and opens in June. Work is planned to start on phase 2 by 2015.

The scheme will bring together clinical and research expertise focused on developing innovative treatment to improve patient care and give individuals the benefit of advances in medical science.

The trust has said groundbreaking new treatments which have never been available in Europe will be trialled and will target diseases such as cancer and HIV.

The OJEU includes architectural services and engineering services, along with QS, M&E consultant and structural engineer roles.

The trust says teams researching immunology, infection and transplantation “will make Hampstead a hub for medical advances and pioneering care for patients with immune-affected conditions”.

It is backed by the Institute of Immunity, Infection and Transplantation and University College London.

Time limit for receipt of tenders or requests to participate is 28 May. Contact Sandy Mehta on 0207 7940500 or email

Have your say

You must sign in to make a comment

Please remember that the submission of any material is governed by our Terms and Conditions and by submitting material you confirm your agreement to these Terms and Conditions. Links may be included in your comments but HTML is not permitted.